CAPSTONE aims at educating future experts in small molecules for immuno- and cancer therapies in the science of antigen processing to deliver new drug prototypes. It is a European Training Network (ETN) composed of 9 beneficiaries, 10 partner organisations and 3 patient associations from 8 EU member states and 1 associated country , including 7 industrial partners